Prevention of cardiovascular disease in patients with type 2 diabetes

被引：2
|
作者：
Lebherz, Corinna [1 ]
Lehrke, Michael [1 ]
机构：
[1] Uniklin Aachen, Kardiol Pneumol Angiol & Internist Intens Med, Aachen, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2015年 / 140卷 / 09期
关键词：
diabetes mellitus; cardiovascular diseases; type; 2; diabetes; ALL-CAUSE MORTALITY; GLUCOSE CONTROL; BARIATRIC SURGERY; GLYCEMIC CONTROL; FOLLOW-UP; RISK; OBESITY; NIACIN; COMPLICATIONS;
D O I：
10.1055/s-0041-101942
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The modern life style is often characterized by a lack of physical activity as well as unhealthy diet leading to a worldwide rise in obesity. This goes along with an increased incidence of type 2 diabetes, accompanied by an accelerated atherosclerosis. Life style changes and normalization of body weight therefore represent the cornerstones of diabetes prevention. In addition, a multi-factorial approach focusing on cardiovascular risk factors like dyslipidemia, hypertension and hyperglycemia enables an effective means for the prevention of micro- or macrovascular complications.
引用
收藏
页码：645 / U16
页数：6
相关论文
共 50 条
  • [21] Plasma metals and cardiovascular disease in patients with type 2 diabetes
    Long, Tengfei
    Wang, Ruixin
    Wang, Jing
    Wang, Fei
    Xu, Yali
    Wei, Yue
    Zhou, Lue
    Zhang, Xiaomin
    Yuan, Jing
    Yao, Ping
    Wei, Sheng
    Guo, Huan
    Yang, Handong
    Wu, Tangchun
    He, Meian
    ENVIRONMENT INTERNATIONAL, 2019, 129 : 497 - 506
  • [22] Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus
    Fujihara, Kazuya
    Sone, Hirohito
    ANNALS OF VASCULAR DISEASES, 2018, 11 (01) : 2 - 14
  • [23] Prevalence of CKD in Patients with Type 2 Diabetes and Cardiovascular Disease
    Yang, J.
    Lu, R.
    Wang, Y.
    Ke, J.
    Huang, W.
    Lu, Q.
    Zhao, D.
    Liu, G.
    Gao, H.
    Hong, T.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [24] Glycemic variability and cardiovascular disease in patients with type 2 diabetes
    Martinez, Marcela
    Santamarina, Jimena
    Pavesi, Adrian
    Musso, Carla
    Umpierrez, Guillermo E.
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [25] Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    Gaede, P
    Vedel, P
    Larsen, N
    Jensen, GVH
    Parving, H
    Pedersen, O
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05): : 383 - 393
  • [26] Protein oxidation and cardiovascular disease in patients with type 2 diabetes
    Bryk, A. H.
    Konieczynska, M.
    Broniatowska, E.
    Undas, A.
    EUROPEAN HEART JOURNAL, 2018, 39 : 905 - 905
  • [27] Fenofibrate for Cardiovascular Disease Prevention in Metabolic Syndrome and Type 2 Diabetes Mellitus
    Steiner, George
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 28L - 33L
  • [28] Exercise for prevention and treatment of cardiovascular disease, type 2 diabetes, and metabolic syndrome
    Gaesser G.A.
    Current Diabetes Reports, 2007, 7 (1) : 14 - 19
  • [29] Secondary prevention of cardiovascular disease using Alphabet Strategy in type 2 diabetes
    Patel, V.
    Lee, J. D.
    Venkataraman, A.
    Morrissey, J.
    DIABETOLOGIA, 2006, 49 : 629 - 630
  • [30] Cardiovascular risks in type 2 diabetes and secondary cardiovascular prevention
    Ducimetière, P
    DIABETES & METABOLISM, 2005, 31 (05) : 503 - 506
12345